Drug intelligence / Profile preview

technetium-99m glucoheptonate

Development stage
Unknown
Lead developer
Philippine Nuclear Research Institute
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium-99m glucoheptonate (99mTc-GH) is a small molecule radiopharmaceutical diagnostic agent used in nuclear medicine for imaging the kidneys, brain, and cardiac blood pool. It consists of the metastable radioisotope Technetium-99m chelated by glucoheptonate ligands. In the Philippines, the Philippine Nuclear Research Institute (PNRI) produces this agent through its Tc-99m Generator Facility for domestic clinical use. The drug is primarily employed to evaluate renal perfusion and function, diagnose acute pyelonephritis, and quantify split renal function. In neurology, it is used to image intracranial lesions where the blood-brain barrier is disrupted, such as brain tumors. Its mechanism of action involves active concentration in renal proximal tubules via organic anion transporters (OATs) and uptake in tumors or inflamed tissues, which is believed to be mediated by glucose transporters like GLUT-1 and GLUT-4.

Brand names
GlucoheptonateGlucoscanTechnescan Gluceptate
Other names
Technetium Tc 99m gluceptatetechnetium-99m gluceptatetechnetium99m gluceptatetechnetium 99m gluceptate99mTc-glucoheptonateTc-99m glucoheptonateTc99m glucoheptonateTc 99m glucoheptonate
02

Targets

GLUT1 (Glucose transporter 1)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)

Beyond the preview

Go deeper on technetium-99m glucoheptonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium-99m glucoheptonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call